BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 31810328)

  • 1. D-loop Mutations in Renal Cell Carcinoma Improve Predictive Accuracy for Cancer-Related Death by Integrating with Mutations in the
    Kim H; Komiyama T; Nitta M; Kawamura Y; Hasegawa M; Shoji S; Orihashi Y; Inomoto C; Kajiwara H; Nakamura N; Kobayashi H; Miyajima A
    Genes (Basel); 2019 Dec; 10(12):. PubMed ID: 31810328
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mutations in the Mitochondrial ND1 Gene Are Associated with Postoperative Prognosis of Localized Renal Cell Carcinoma.
    Kim H; Komiyama T; Inomoto C; Kamiguchi H; Kajiwara H; Kobayashi H; Nakamura N; Terachi T
    Int J Mol Sci; 2016 Dec; 17(12):. PubMed ID: 27941608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of recurrent copy number alterations and cancer gene mutations on the predictive accuracy of prognostic models in clear cell renal cell carcinoma.
    Hakimi AA; Mano R; Ciriello G; Gonen M; Mikkilineni N; Sfakianos JP; Kim PH; Motzer RJ; Russo P; Reuter VE; Hsieh JJ; Ostrovnaya I
    J Urol; 2014 Jul; 192(1):24-9. PubMed ID: 24518768
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single nucleotide polymorphisms in the D-loop region of mitochondrial DNA is associated with renal cell carcinoma outcome.
    Bai Y; Guo Z; Xu J; Liu S; Zhang J; Cui L; Zhang H; Zhang S
    Mitochondrial DNA; 2015 Apr; 26(2):224-6. PubMed ID: 24021012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomically annotated risk model for advanced renal-cell carcinoma: a retrospective cohort study.
    Voss MH; Reising A; Cheng Y; Patel P; Marker M; Kuo F; Chan TA; Choueiri TK; Hsieh JJ; Hakimi AA; Motzer RJ
    Lancet Oncol; 2018 Dec; 19(12):1688-1698. PubMed ID: 30416077
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carbonic anhydrase IX is an independent predictor of survival in advanced renal clear cell carcinoma: implications for prognosis and therapy.
    Bui MH; Seligson D; Han KR; Pantuck AJ; Dorey FJ; Huang Y; Horvath S; Leibovich BC; Chopra S; Liao SY; Stanbridge E; Lerman MI; Palotie A; Figlin RA; Belldegrun AS
    Clin Cancer Res; 2003 Feb; 9(2):802-11. PubMed ID: 12576453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Factors for Renal Cell Carcinoma Subtypes Diagnosed According to the 2016 WHO Renal Tumor Classification: a Study Involving 928 Patients.
    Kuthi L; Jenei A; Hajdu A; Németh I; Varga Z; Bajory Z; Pajor L; Iványi B
    Pathol Oncol Res; 2017 Jul; 23(3):689-698. PubMed ID: 28032311
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification and validation of novel prognostic markers in Renal Cell Carcinoma.
    Rabjerg M
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acquired Cystic Kidney Disease-associated Renal Cell Carcinoma (ACKD-RCC) Harbor Recurrent Mutations in KMT2C and TSC2 Genes.
    Shah A; Lal P; Toorens E; Palmer MB; Schwartz L; Vergara N; Guzzo T; Nayak A
    Am J Surg Pathol; 2020 Nov; 44(11):1479-1486. PubMed ID: 32604168
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and Impact of TERT Promoter Region Mutations on Clinical Outcome in Renal Cell Carcinoma.
    Casuscelli J; Becerra MF; Manley BJ; Zabor EC; Reznik E; Redzematovic A; Arcila ME; Tennenbaum DM; Ghanaat M; Kashan M; Stief CG; Carlo M; Voss MH; Feldman DR; Motzer RJ; Chen Y; Reuter VE; Coleman JA; Russo P; Hsieh JJ; Hakimi AA
    Eur Urol Focus; 2019 Jul; 5(4):642-649. PubMed ID: 28951115
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Succinate dehydrogenase B: a new prognostic biomarker in clear cell renal cell carcinoma.
    Cornejo KM; Lu M; Yang P; Wu S; Cai C; Zhong WD; Olumi A; Young RH; Wu CL
    Hum Pathol; 2015 Jun; 46(6):820-6. PubMed ID: 25827535
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive Genomic Analysis of Translocation Renal Cell Carcinoma Reveals Copy-Number Variations as Drivers of Disease Progression.
    Marcon J; DiNatale RG; Sanchez A; Kotecha RR; Gupta S; Kuo F; Makarov V; Sandhu A; Mano R; Silagy AW; Blum KA; Nassau DE; Benfante NE; Ortiz MV; Carlo MI; Chan TA; Motzer RJ; Voss MH; Coleman J; Russo P; Reuter V; Hakimi AA; Reznik E
    Clin Cancer Res; 2020 Jul; 26(14):3629-3640. PubMed ID: 32220885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Multigene Signature Based on Cell Cycle Proliferation Improves Prediction of Mortality Within 5 Yr of Radical Nephrectomy for Renal Cell Carcinoma.
    Morgan TM; Mehra R; Tiemeny P; Wolf JS; Wu S; Sangale Z; Brawer M; Stone S; Wu CL; Feldman AS
    Eur Urol; 2018 May; 73(5):763-769. PubMed ID: 29249291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. ALK alterations in adult renal cell carcinoma: frequency, clinicopathologic features and outcome in a large series of consecutively treated patients.
    Sukov WR; Hodge JC; Lohse CM; Akre MK; Leibovich BC; Thompson RH; Cheville JC
    Mod Pathol; 2012 Nov; 25(11):1516-25. PubMed ID: 22743654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic Value of a Long Non-coding RNA Signature in Localized Clear Cell Renal Cell Carcinoma.
    Qu L; Wang ZL; Chen Q; Li YM; He HW; Hsieh JJ; Xue S; Wu ZJ; Liu B; Tang H; Xu XF; Xu F; Wang J; Bao Y; Wang AB; Wang D; Yi XM; Zhou ZK; Shi CJ; Zhong K; Sheng ZC; Zhou YL; Jiang J; Chu XY; He J; Ge JP; Zhang ZY; Zhou WQ; Chen C; Yang JH; Sun YH; Wang LH
    Eur Urol; 2018 Dec; 74(6):756-763. PubMed ID: 30143382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Mitochondrial DNA Copy Number Alteration in Human Renal Cell Carcinoma.
    Lin CS; Lee HT; Lee MH; Pan SC; Ke CY; Chiu AW; Wei YH
    Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27231905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative Genomic Profiling of Matched Primary and Metastatic Tumors in Renal Cell Carcinoma.
    Becerra MF; Reznik E; Redzematovic A; Tennenbaum DM; Kashan M; Ghanaat M; Casuscelli J; Manley B; Jonsson P; DiNatale RG; Blum KA; Durack JC; Solomon SB; Arcila ME; Bourque C; Socci N; Carlo MI; Lee CH; Voss MH; Feldman DR; Motzer RJ; Coleman JA; Russo P; Cheng EH; Hakimi AA; Hsieh JJ
    Eur Urol Focus; 2018 Dec; 4(6):986-994. PubMed ID: 29066084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Somatic VHL alteration and its impact on prognosis in patients with clear cell renal cell carcinoma.
    Kim JH; Jung CW; Cho YH; Lee J; Lee SH; Kim HY; Park J; Park JO; Kim K; Kim WS; Park YS; Im YH; Kang WK; Park K
    Oncol Rep; 2005 May; 13(5):859-64. PubMed ID: 15809750
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single nucleotide variants of succinate dehydrogenase A gene in renal cell carcinoma.
    Kamai T; Higashi S; Murakami S; Arai K; Namatame T; Kijima T; Abe H; Jamiyan T; Ishida K; Shirataki H; Yoshida KI
    Cancer Sci; 2021 Aug; 112(8):3375-3387. PubMed ID: 34014604
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Novel Oncogene with Kinase-Domain (NOK) Gene Expression is Associated with the Progression of Renal Cell Carcinoma.
    Cao Q; Chen M; Li Z; Huang W; Jin Y; Ye X; Tong M
    Clin Lab; 2016; 62(1-2):179-86. PubMed ID: 27012048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.